Pulmonary inflammatory myofibroblastic tumour after Hodgkin's lymphoma.
Positron emission tomography (PET)/CT plays a major role in staging, assessing response to treatment and during follow-up of paediatric Hodgkin's lymphoma (HL). Owing to high sensitivity to detect viable tumoural tissue, negative PET/CT is highly predictive of survival. However, (18)F-FDG is not specific for malignant disease and may concentrate in numerous benign/inflammatory lesions that may cause 'false-positive' results and follow-up PET/CT studies should be interpreted with caution. We report a case of pulmonary inflammatory myofibroblastic tumour, which developed during follow-up in a young patient with complete remission of a stage IIB HL and was fully treated with surgical resection.
Department of Nuclear Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Vesna
V
Ilic
Vincent
V
Dunet
Maja
M
Beck-Popovic
Ariane
A
Boubaker
D000293:Adolescent; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D009367:Neoplasm Staging; D016726:Plasma Cell Granuloma, Pulmonary / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D011013:Pneumonectomy / Q000379:methods; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed